<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
66406-0223-2
</NDCCode>
<PackageDescription>
144 BOTTLE in 1 CASE (66406-0223-2) > 150 TABLET in 1 BOTTLE (66406-0223-1)
</PackageDescription>
<NDC11Code>
66406-0223-02
</NDC11Code>
<ProductNDC>
66406-0223
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Tizanidine Hydrochloride
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName/>
<StartMarketingDate>
19970101
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Patheon Inc.
</LabelerName>
<SubstanceName>
TIZANIDINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
4
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2014-02-04
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20171231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>